Australia markets closed

Triterras, Inc. (TRIRF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5000-0.0200 (-3.85%)
At close: 03:57PM EST
Full screen
Loading interactive chart…
  • GlobeNewswire

    Triterras Reports Financial Results for the Six Months Ended August 31, 2022

    SINGAPORE, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Triterras Inc. (OTC Expert Market: TRIRF) (“Triterras” or the “Company”), a leading fintech company focused on trade and trade finance, today reported its financial results for the six-months ended August 31, 2022, representing the first half of the Company’s 2023 fiscal year. Mr. Srinivas Koneru, the Company’s Chairman and Chief Executive Officer commented, “The first half of fiscal year 2023 was clearly very challenging for the Company. Although glo

  • GlobeNewswire

    Triterras Schedules First Half Fiscal 2023 Conference Call for Wednesday, November 30, 2022 at 8:15 a.m. ET

    SINGAPORE, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Triterras Inc. (OTC Expert Market: TRIRF) (“Triterras” or the “Company”), a leading fintech company focused on trade and trade finance, plans to release results for the first half of fiscal 2023 covering the six-months ended August 31, 2022 before the market opens on November 30, 2022. The Company will hold a conference call on Wednesday, November 30, 2022 at 8:15 am Eastern Time where management will provide a business and operational update during t

  • GlobeNewswire

    Triterras Announces Final Court Approval of Previously Disclosed Settlement of Securities Class Action Litigation

    SINGAPORE, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Triterras Inc. (OTC Expert Market: TRIRF) (“Triterras” or the “Company”), a leading fintech company focused on trade and trade finance, today reported that on September 8, 2022 the Company received final court approval to settle the securities class action lawsuit under the caption Erlandson v. Triterras, Inc., et al. (Civil Action No. 7:20-cv-10795-CS (S.D.N.Y.)). The settlement resolves all claims asserted against the Company and the other named de